COLL compared with LPLA: revenue, margins and what each company keeps, and the suppliers and customers both name

COLLCollegium Pharmaceutical, Inc

Mkt capRevenueRevenue

LPLALPL Financial Holdings Inc.

Mkt capRevenueRevenue

Compare

COLLCollegium Pharmaceutical, Inc

LPLALPL Financial Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only COLL 2

—Hikma Pharmaceuticals USAunlistedsupplier

—Grünenthalunlistedsupplier

Shared 0

No shared counterparties.

Only LPLA 17

PRUPrudentialsupplier

MTBM&T Bankcustomer

WTFCWintrust Financialcustomer

INDBIndependent Bankcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

13 more · LPLA chain ›

COLLCollegium Pharmaceutical, Inc

23.66▼−0.30%· post 23.66· delayed

Mkt cap$772.5MRevenue$200MQ2 FY26Revenue$781MFY25

LPLALPL Financial Holdings Inc.

311.24▲+4.56%· post 312.28· delayed

After hoursNov 4 '26delayed

Mkt cap$23.2BRevenue$5.3BQ3 FY26Revenue$17.0BFY25

Compare

After hoursNov 4 '26delayed

COLLCollegium Pharmaceutical, Inc

LPLALPL Financial Holdings Inc.

23.66▼−0.30%post 23.66delayed

Price

311.24▲+4.56%post 312.28delayed

$772.5M

Mkt cap

$23.2B

Q2 FY26$200M

Revenue

$5.3BQ3 FY26

FY25$781M

Revenue

$17.0BFY25

COLL23.66▼−0.30%vsLPLA311.24▲+4.56%After hoursNov 4 '26delayed